CLNT [Cleantech Solutions International] 8-K: (Original Filing)

[Company Contact: Mr. Ryan Hua Vice President of Operations Cleantech Solutions International, Inc. ryanhua@cleantechsolutionsinternational.com Email: www.cleantechsolutionsinternational.com Web: Investor Relations Contact: Ms. Elaine Ketchmere CCG Investor Relations Tel: +1-310-954-1345 elaine.ketchmere@ccgir.com Email: www.ccgirasia.com Web: Cleantech Solutions International Reports First Quarter 2012 Results Wuxi, Jiangsu Province, China In the first quarter, we experienced soft demand for our forged]

CLNT [Cleantech Solutions International] 8-K: Company Contact: Mr. Ryan Hua Vice President of

[Company Contact: Mr. Ryan Hua Vice President of Operations Cleantech Solutions International, Inc. ryanhua@cleantechsolutionsinternational.com Email: www.cleantechsolutionsinternational.com Web: Investor Relations Contact: Ms. Elaine Ketchmere CCG Investor Relations Tel: +1-310-954-1345 elaine.ketchmere@ccgir.com Email: www.ccgirasia.com Web: Cleantech Solutions International Reports First Quarter 2012 Results Wuxi, Jiangsu Province, China In the first quarter, we experienced soft demand for our forged]

GSOL [GLOBAL SOURCES] 6-K: (Original Filing)

[st YEAR 2012 / 1 RESULTS OF OPERATIONS OF GLOBAL SOURCES LTD. The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater] [GLOBAL SOURCES LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In U.S. Dollars Thousands, Except Number of Shares and Per Share Data) As at March 31, As at December 31, 2012 2011 (Unaudited) ASSETS Current assets Cash and cash equivalents $ 83,218 $ 81,903 Term deposits with banks 2,043 2,764 Financial assets, available-for-sale 7,999 13,250 Accounts receivables 4,279 4,711 Receivables from sales]

By | 2016-03-07T17:43:43+00:00 May 18th, 2012|Categories: Chinese Stocks, GSOL, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited First Quarter 2012 Financial Results – Conference call scheduled for Tuesday, May 15, 2012 at 8:00 AM EDT – – Sinovac Biotech Ltd. ( today its unaudited first quarter Beijing – May 15, 2012 Financial Highlights (year-over-year comparisons to first quarter 2011) · Sales increased 30.3% to $6.0 million, with Bilive vaccines sales up 92.4%. · Gross] []

By | 2016-03-24T01:08:26+00:00 May 18th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

GSOL [GLOBAL SOURCES] 6-K: st YEAR 2012 / 1 RESULTS OF OPERATIONS

[st YEAR 2012 / 1 RESULTS OF OPERATIONS OF GLOBAL SOURCES LTD. The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater] [GLOBAL SOURCES LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In U.S. Dollars Thousands, Except Number of Shares and Per Share Data) As at March 31, As at December 31, 2012 2011 (Unaudited) ASSETS Current assets Cash and cash equivalents $ 83,218 $ 81,903 Term deposits with banks 2,043 2,764 Financial assets, available-for-sale 7,999 13,250 Accounts receivables 4,279 4,711 Receivables from sales]

By | 2016-03-07T17:45:42+00:00 May 18th, 2012|Categories: Chinese Stocks, GSOL, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Quarter 2012 Financial Results

[Sinovac Reports Unaudited First Quarter 2012 Financial Results – Conference call scheduled for Tuesday, May 15, 2012 at 8:00 AM EDT – – Sinovac Biotech Ltd. ( today its unaudited first quarter Beijing – May 15, 2012 Financial Highlights (year-over-year comparisons to first quarter 2011) · Sales increased 30.3% to $6.0 million, with Bilive vaccines sales up 92.4%. · Gross] []

By | 2016-03-24T01:09:41+00:00 May 18th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar